RephImmune Biotechnology Revenue
Biotechnology Research • 
China • 1-10 Employees
$
RephImmune Biotechnology revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at RephImmune Biotechnology
Fang Zhou
Co-Founder
Company overview
| Headquarters | China |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
About RephImmune Biotechnology
We created novel genome-engineered cell therapy named RACE to treat solid tumors. Our first product aims to combat the most lethal cancer in female malignancies
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
RephImmune Biotechnology has 1 employees across 1 departments.
Departments
Number of employees
RephImmune Biotechnology Tech Stack
Discover the technologies and tools that power RephImmune Biotechnology's digital infrastructure, from frameworks to analytics platforms.
Security
Miscellaneous
JavaScript libraries
CMS
JavaScript libraries
Font scripts
United Arab Emirates
Ukraine
Finland
Canada
Frequently asked questions
RephImmune Biotechnology is located in CN.
RephImmune Biotechnology generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.
RephImmune Biotechnology has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
RephImmune Biotechnology has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
